InMed Pharmaceuticals Inc. (NASDAQ: INM) Stock Information | RedChip

InMed Pharmaceuticals Inc. (NASDAQ: INM) Listen to this Section


$0.15
+0.0042 ( +2.98% ) 89.9K

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Market Data


Open


$0.15

Previous close


$0.14

Volume


89.9K

Market cap


$1.33M

Day range


$0.14 - $0.15

52 week range


$0.12 - $2.08

Insider Ownership Transactions

Total Amount Purchased: -389,400.00 | $ -56,463.00

Date Type Amount Purchased Purchaser
2023-12-26 Sale -7100.00 HULL ANDREW
2023-12-26 Sale -45000.00 MANCINI ALEXANDRA DIANE JANET
2023-12-26 Sale -136000.00 ADAMS ERIC A
2023-12-26 Sale -40000.00 Johnson Shane Aaron
2023-12-26 Sale -7100.00 Baldasare Bryan T
2023-12-26 Sale -65000.00 WOUDENBERG MICHAEL
2023-12-26 Sale -30000.00 Tegge Jonathan
2023-12-26 Sale -7100.00 Grove Janet P
2023-12-26 Sale -45000.00 HSU ERIC C
2023-12-26 Sale -7100.00 Lemerond Nicole

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 16 Apr 18, 2024
8-k 8K-related 16 Apr 16, 2024
8-k 8K-related 16 Apr 05, 2024
8-k 8K-related 15 Mar 20, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024
3 Insider transactions 2 Feb 27, 2024
4 Insider transactions 1 Feb 22, 2024
4 Insider transactions 1 Feb 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.